Bone Biologics Corp (BBLG)
1.465
-0.14
(-8.44%)
USD |
NASDAQ |
Apr 24, 16:00
1.465
0.00 (0.00%)
After-Hours: 19:04
Bone Biologics Total Assets (Quarterly): 3.738M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.738M |
| September 30, 2023 | 4.976M |
| June 30, 2023 | 7.623M |
| March 31, 2023 | 6.784M |
| December 31, 2022 | 8.495M |
| September 30, 2022 | 5.201M |
| June 30, 2022 | 5.659M |
| March 31, 2022 | 6.094M |
| December 31, 2021 | 6.675M |
| September 30, 2021 | 0.0524M |
| June 30, 2021 | 0.0044M |
| March 31, 2021 | 0.0712M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.0025M |
| June 30, 2020 | 0.0014M |
| March 31, 2020 | 0.007M |
| December 31, 2019 | 0.0308M |
| Date | Value |
|---|---|
| September 30, 2019 | 0.2493M |
| June 30, 2019 | 0.2664M |
| March 31, 2019 | 0.8141M |
| December 31, 2018 | 1.041M |
| September 30, 2018 | 2.350M |
| June 30, 2018 | 0.3777M |
| March 31, 2018 | 0.4705M |
| December 31, 2017 | 0.7957M |
| September 30, 2017 | 1.940M |
| June 30, 2017 | 1.140M |
| March 31, 2017 | 1.968M |
| December 31, 2016 | 0.7011M |
| September 30, 2016 | 1.072M |
| June 30, 2016 | 2.635M |
| March 31, 2016 | 4.622M |
| December 31, 2015 | 1.547M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2020
8.495M
Maximum
Dec 2022
2.944M
Average
0.2664M
Median
Jun 2019
Total Assets (Quarterly) Benchmarks
| BioVie Inc | 21.49M |
| Krystal Biotech Inc | 818.36M |
| Adial Pharmaceuticals Inc | 4.737M |
| Processa Pharmaceuticals Inc | 5.787M |
| Calidi Biotherapeutics Inc | 10.02M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.8314M |
| Shareholders Equity (Quarterly) | 2.906M |